X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58) 58
diabetes (42) 42
male (33) 33
female (30) 30
endocrinology & metabolism (28) 28
type 2 diabetes (25) 25
middle aged (23) 23
risk factors (20) 20
diabetes mellitus, type 2 - drug therapy (19) 19
care and treatment (18) 18
clinical trials (17) 17
adult (16) 16
aged (16) 16
drug therapy (16) 16
abridged index medicus (15) 15
glucose (14) 14
research (14) 14
hyperglycemia (13) 13
clinical neurology (12) 12
diabetes therapy (12) 12
hypoglycemic agents - therapeutic use (12) 12
migraine (12) 12
patients (11) 11
blood glucose - metabolism (10) 10
diabetes mellitus, type 2 - complications (10) 10
health aspects (10) 10
insulin (10) 10
prevalence (10) 10
treatment outcome (10) 10
cardiovascular (9) 9
diagnosis (9) 9
double-blind method (9) 9
hypoglycemic agents (9) 9
hypoglycemic agents - administration & dosage (9) 9
internal medicine (9) 9
mellitus (9) 9
prevention (9) 9
risk (9) 9
studies (9) 9
adolescent (8) 8
cardiovascular disease (8) 8
cardiovascular diseases (8) 8
diabetes mellitus, type 2 - blood (8) 8
disease (8) 8
glycated hemoglobin a - analysis (8) 8
glycated hemoglobin a - metabolism (8) 8
glycemic control (8) 8
headache (8) 8
medicine, general & internal (8) 8
mortality (8) 8
peptides - administration & dosage (8) 8
venoms - administration & dosage (8) 8
cardiac & cardiovascular systems (7) 7
drug administration schedule (7) 7
efficacy (7) 7
epidemiology (7) 7
health (7) 7
medical research (7) 7
metformin (7) 7
obesity (7) 7
pharmaceutical industry (7) 7
therapy (7) 7
complications and side effects (6) 6
diabetes mellitus, type 1 - blood (6) 6
diabetics (6) 6
dosage and administration (6) 6
headaches (6) 6
heart attacks (6) 6
hypoglycemic agents - adverse effects (6) 6
impact (6) 6
insulin-resistance (6) 6
liraglutide (6) 6
original research (6) 6
peptides - therapeutic use (6) 6
research submissions (6) 6
safety (6) 6
united-states (6) 6
venoms - therapeutic use (6) 6
adults (5) 5
analysis (5) 5
blood glucose - analysis (5) 5
blood glucose - drug effects (5) 5
body mass index (5) 5
child (5) 5
children (5) 5
comparative analysis (5) 5
coronary-heart-disease (5) 5
diabetes mellitus (5) 5
diabetes mellitus, type 2 - diagnosis (5) 5
glucagon-like peptide 1 - analogs & derivatives (5) 5
glycated hemoglobin a - drug effects (5) 5
hypoglycemia (5) 5
insulin glargine (5) 5
management (5) 5
methods (5) 5
microvascular complications (5) 5
pediatrics (5) 5
peptides - adverse effects (5) 5
quality-of-life (5) 5
reproducibility of results (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 103 - 110
Exenatide once-weekly is an extended release formulation of exenatide, a glucagon-like peptide–1 receptor agonist, which can improve glycemic control, body... 
Cardiovascular | DIABETES-MELLITUS | HEART | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | PIOGLITAZONE | GLUCAGON-LIKE PEPTIDE-1 | SAFETY | RECEPTOR AGONISTS | GLUCOSE | CLINICAL-TRIALS | DISEASE | Risk Assessment - methods | United States - epidemiology | Glucagon-Like Peptide 1 | Prognosis | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Peptides - administration & dosage | Incidence | Dose-Response Relationship, Drug | Microspheres | Hypoglycemic Agents - administration & dosage | Time Factors | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Venoms - administration & dosage | Adult | Female | Diabetes Mellitus, Type 2 - complications | Cardiovascular Diseases - etiology | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Factors | China - epidemiology | Diabetes Mellitus, Type 2 - blood | Ontario - epidemiology | Italy - epidemiology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Hypoglycemic agents | Glucagon | Cardiac patients | Heart attack | Corporate sponsorship | Heart attacks | Research & development--R&D | Pragmatism | Cardiovascular disease | Diabetes | Pharmaceutical industry | Patients | Cholesterol
Journal Article
Journal Article
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2007, Volume 99, Issue 12, pp. S4 - S20
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article